Description

ALGREE 180 MG

Indications

ALGREE 180 MG is primarily indicated for the relief of symptoms associated with allergic rhinitis, including sneezing, runny or itchy nose, and itchy or watery eyes. It is also used in the management of chronic urticaria (hives), providing relief from itching and discomfort. This medication is suitable for adults and children over the age of 12 who experience these allergic symptoms.

Mechanism of Action

ALGREE contains the active ingredient bilastine, which is a second-generation antihistamine. It works by selectively blocking peripheral H1 receptors, thereby inhibiting the action of histamine, a substance in the body that is responsible for allergic symptoms. By preventing histamine from binding to its receptors, ALGREE effectively reduces the symptoms of allergic reactions without causing significant sedation, which is a common side effect associated with first-generation antihistamines.

Pharmacological Properties

Bilastine is characterized by its rapid absorption and high bioavailability, with peak plasma concentrations typically reached within 1 to 2 hours after oral administration. It has a long duration of action, allowing for once-daily dosing. The drug is primarily metabolized in the liver, and its metabolites are excreted mainly through the urine. Due to its low penetration into the central nervous system, bilastine is less likely to cause sedation compared to older antihistamines. The pharmacokinetic profile of ALGREE supports its efficacy and safety in managing allergic conditions.

Contraindications

ALGREE 180 MG is contraindicated in individuals with a known hypersensitivity to bilastine or any of the excipients in the formulation. It should not be used in patients with severe renal impairment, as the drug’s clearance may be significantly reduced in this population. Additionally, caution is advised in patients with a history of cardiovascular disease, as antihistamines can potentially affect heart rhythm.

Side Effects

Common side effects associated with ALGREE 180 MG include headache, drowsiness, fatigue, and dry mouth. These effects are generally mild and transient. In rare cases, some individuals may experience more severe adverse reactions such as palpitations, allergic reactions, or gastrointestinal disturbances. Patients are advised to report any unusual or severe side effects to their healthcare provider promptly.

Dosage and Administration

The recommended dosage of ALGREE 180 MG for adults and children aged 12 years and older is one tablet taken once daily, preferably on an empty stomach. The tablet should be swallowed whole with water and should not be chewed or crushed. It is important for patients to adhere to the prescribed dosage and not exceed the recommended amount, as this may increase the risk of adverse effects.

Interactions

ALGREE 180 MG may interact with certain medications, which can alter its efficacy or increase the risk of side effects. Caution is advised when co-administering bilastine with other central nervous system depressants, such as alcohol, benzodiazepines, or opioids, as these may enhance sedative effects. Additionally, medications that affect liver enzymes, particularly CYP3A4 inhibitors, may impact the metabolism of bilastine. It is essential for patients to inform their healthcare provider of all medications they are currently taking to avoid potential interactions.

Precautions

Before starting treatment with ALGREE 180 MG, patients should disclose their complete medical history, especially any history of kidney disease, heart conditions, or allergies. Pregnant or breastfeeding women should consult their healthcare provider before using this medication, as the safety of bilastine in these populations has not been fully established. Patients should also avoid driving or operating heavy machinery until they know how ALGREE affects them, particularly if they experience drowsiness or fatigue.

Clinical Studies

Clinical studies have demonstrated the efficacy and safety of ALGREE 180 MG in treating allergic rhinitis and chronic urticaria. In randomized controlled trials, bilastine has been shown to significantly reduce nasal and ocular symptoms compared to placebo, with a favorable safety profile. The long-lasting effects of bilastine allow for once-daily dosing, which enhances patient compliance. Furthermore, studies have indicated that bilastine does not impair cognitive function or psychomotor performance, making it a suitable option for individuals who require alertness during daily activities.

Conclusion

ALGREE 180 MG is an effective antihistamine for the management of allergic rhinitis and chronic urticaria. Its mechanism of action, pharmacological properties, and favorable side effect profile make it a valuable option for patients suffering from allergic conditions. As with any medication, it is crucial for patients to use ALGREE responsibly and under the guidance of a healthcare professional to ensure optimal outcomes and minimize risks.